Currently holds positions in Fennec Pharmaceuticals Inc and Arch Biopartners Inc
Position | Company | Period |
---|---|---|
Independent Director | Fennec Pharmaceuticals Inc | April 28, 2014 - |
Independent Director | Arch Biopartners Inc | Dec. 1, 2014 - |
Interim Director | Arch Biopartners Inc | Aug. 21, 2014 - Dec. 1, 2014 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-04-22 | 2024-04-22 |
Fennec Pharmaceuticals Inc
(FENC)
|
PS Planned sale |
22,223
-100.0%
9.32207,029 USD |
22,223 -100.0% | 9.32 | 207,029 USD | |
2024-04-22 | 2024-04-19 |
Fennec Pharmaceuticals Inc
(FENC)
|
PS Planned sale |
22,222
-100.0%
9.34207,442 USD |
22,222 -100.0% | 9.34 | 207,442 USD | |
2024-04-18 | 2024-04-18 |
Fennec Pharmaceuticals Inc
(FENC)
|
PS Planned sale |
22,222
-100.0%
9.62213,776 USD |
22,222 -100.0% | 9.62 | 213,776 USD | |
2024-04-18 | 2024-04-17 |
Fennec Pharmaceuticals Inc
(FENC)
|
PS Planned sale |
22,222
-50.0%
9.91220,220 USD |
22,222 -50.0% | 9.91 | 220,220 USD | |
2024-04-16 | 2024-04-16 |
Fennec Pharmaceuticals Inc
(FENC)
|
PS Planned sale |
22,222
-100.0%
10.28228,389 USD |
22,222 -100.0% | 10.28 | 228,389 USD | |
2024-04-16 | 2024-04-15 |
Fennec Pharmaceuticals Inc
(FENC)
|
PS Planned sale |
22,222
-50.0%
10.30228,793 USD |
22,222 -50.0% | 10.30 | 228,793 USD |